Cleared Traditional

K863934 - DPC COAT-A-COUNT IRMA LH KIT

K863934 is the FDA 510(k) clearance for DPC COAT-A-COUNT IRMA LH KIT by Diagnostic Products Corp.. It is a Class 1 Chemistry device (product code CEP) cleared through the Traditional 510(k) pathway after a 120-day FDA review.

K863934 · Diagnostic Products Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1987
Decision
120d
Days
Class 1
Risk

K863934 is an FDA 510(k) clearance for the DPC COAT-A-COUNT IRMA LH KIT. Classified as Radioimmunoassay, Luteinizing Hormone (product code CEP), Class I - General Controls.

Submitted by Diagnostic Products Corp. (Los Angeles, US). The FDA issued a Cleared decision on February 6, 1987 after a review of 120 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1485 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Diagnostic Products Corp. devices

Submission Details

510(k) Number K863934 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 09, 1986
Decision Date February 06, 1987
Days to Decision 120 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
32d slower than avg
Panel avg: 88d · This submission: 120d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code CEP Radioimmunoassay, Luteinizing Hormone
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1485
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CEP Radioimmunoassay, Luteinizing Hormone

All 58
Devices cleared under the same product code (CEP) and FDA review panel - the closest regulatory comparables to K863934.
STRATUS(R) HLH FLUOROMETRIC ENZYME IMMUNOASSAY
K873052 · American Dade · Sep 1987
TANDEMR M-PAK LH IMMUNOENZYMETRIC ASSAY
K872131 · Hybritech, Inc. · Aug 1987
CLEARPLAN
K871332 · Unipath , Ltd. · Aug 1987
TERUMO SENSIBEAD(TM) EIA HLH KIT
K863929 · Terumo Medical Corp. · Nov 1986
ALLEGRO LUTEINIZING HORMONE IMMUNOASSAY SYSTEM
K863679 · Nichols Institute Diagnostics · Oct 1986
RIGHT-DAY OVULATION HOME TEST
K861354 · Leeco Diagnostics, Inc. · Sep 1986